Mesoblast's stem cells "significantly superior" in preclinical neck fusion trial
This article was originally published in Clinica
Executive Summary
The allogeneic cell therapy developed by Mesoblast has been proven safe and "highly effective" in preclinical trials testing its use for interbody fusion of the tissue between neck bones.